Skip to main content

Table 1 Inclusion criteria for the four groups used in the present study

From: Influence of APOE genotype in primary age-related tauopathy

Study group Characteristics for inclusion
Normal pathology for age Braak stage 0
Thal phase 0–1
No other significant pathological changes
AD pathological changes Braak stage III or higher
Thal phase 3 or higher
No other significant pathological changes
Possible PART Braak stage III or lower
Thal phase 1–2
No other disease associated with NFTs present
Definite PART Braak stage III or lower
Thal phase 0
No other disease associated with NFTs present